Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects

類似資料

• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Rising TAK-438 (Vonoprazan) Doses in Healthy Male Japanese/non-Japanese Subjects
  著者:: Sakurai, Yuuichi, 等
  出版事項: (2015)
• Randomised clinical trial: vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
  著者:: Ashida, K., 等
  出版事項: (2015)
• Randomised clinical trial: a dose‐ranging study of vonoprazan, a novel potassium‐competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
  著者:: Ashida, K., 等
  出版事項: (2015)
• The binding selectivity of vonoprazan (TAK-438) to the gastric H(+),K(+)−ATPase
  著者:: Scott, David R., 等
  出版事項: (2015)
• Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of Helicobacter pylori
  著者:: Yamada, Shinya, 等
  出版事項: (2016)